- Why Research
- Our Impact
- Get Involved
- About BCRF
- Research is the reason
- Contact Us
- The Hot Pink Party
You are here
A mathematical modeling software initially created to analyze breast cancer cells is now helping investigators understand SARS-CoV-2
Dr. Andrew Ewald and colleagues report that ubiquitous statins selectively kill cancerous cells and open up a new area for research
How the patient experience is informing research from the bench to bedside
AACR Annual Meeting 2020 Highlights: Potential New Treatment Options for Patients with High-Risk Breast Cancers
Researchers present findings on PARP inhibitors and novel immunotherapy combinations at the first of two virtual AACR conferences
In the first study of its kind, Dr. Matthew Ellis demonstrates the clinical value of scaled down proteogenomic analysis of breast tumor biopsies
In recognition of National Minority Health Month, we take a look at how breast cancer affects minorities—and what BCRF researchers are doing to close gaps in outcomes.
BCRF researchers Drs. Jill Bargonetti and Funmi Olopade collaborated to investigate potential biomarkers and a targeted treatment for this aggressive form of the disease.
Results show positive impact on biomarkers for breast cancer risk and could improve patient outcomes.
Novel cancer therapies used in combination with common treatments are extending lives of patients with advanced and high-risk breast cancers.
BCRF-sponsored symposium connects scientists, clinicians, and private industry to share research developments.